跳至主要内容
临床试验/EUCTR2015-000709-38-AT
EUCTR2015-000709-38-AT进行中(未招募)1 期

Acute Effects of Benzbromaron on the pulmonary circulation

Medical University of Graz0 个研究点开始时间: 2015年7月28日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • informed consent
  • diagnosis of pulmonary arterial hypertension
  • age: 18-90 years
  • Medically indicated right heart catheterization
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • known allergy against benzbromaron, gelborange S or another component of the drug or against a drug with similar chemical structure
  • decreased renal function (GFR<60ml/min/kg)
  • renal diathesis
  • severe lilver disease (Bilirubin >1.6 mg% or AST or ALT > 3x ULN)
  • known pregnancy
  • uncontrolled systemic arterial hypertension (at rest >150 mmHg systolic or 95 mmHg diastolic)
  • uncontrolled ventricular arrythmias
  • uncontrolled bradycard or tachycard supraventricular arrythmias
  • myicardial infarction in the last 12 months
  • acute pulmonary embolism in the last 6 months
  • ongoing iv or sc Prostanoidtherapy for pulmonary arterial hypertension

研究者

发起方
Medical University of Graz

相似试验